Traders assign an 81.5% probability to no new COVID variant of concern emerging before 2027 because ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve through Omicron sublineages such as XFG without crossing the thresholds for increased transmissibility, severity, or immune escape that would trigger official designation. Recent monitoring reports through April 2026 confirm no variants currently meet variant-of-concern criteria, with strains like BA.3.2 remaining under observation but producing no widespread spikes in hospitalizations or vaccine breakthrough cases. This pattern aligns with the post-Omicron stabilization seen since late 2024, where incremental mutations have prompted routine vaccine updates rather than disruptive new threats.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоДа
$238,975 Объем
$238,975 Объем
Да
$238,975 Объем
$238,975 Объем
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Открытие рынка: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Traders assign an 81.5% probability to no new COVID variant of concern emerging before 2027 because ongoing genomic surveillance shows SARS-CoV-2 continuing to evolve through Omicron sublineages such as XFG without crossing the thresholds for increased transmissibility, severity, or immune escape that would trigger official designation. Recent monitoring reports through April 2026 confirm no variants currently meet variant-of-concern criteria, with strains like BA.3.2 remaining under observation but producing no widespread spikes in hospitalizations or vaccine breakthrough cases. This pattern aligns with the post-Omicron stabilization seen since late 2024, where incremental mutations have prompted routine vaccine updates rather than disruptive new threats.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы